How one drug maker cut drug type ID from months to weeks
Transforming Drug Discovery Through Data-Centric Approach
Recursion Pharmaceuticals managed to create an innovative data-first approach to biological research that dramatically decreased costs and increased efficiency.
However, their high throughput platform required AI and machine learning enabled processing and created a large amount of small file sizes, which lead to massive overhead and performance bottlenecks for critical workloads.
Access this case study to learn about DataDirect Networks, the high-performance hybrid data management solution Recursion Pharmaceuticals implemented which allows fast access to millions of small files and extended attributes while automatically tiering data to more efficient spinning disk.